BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29877150)

  • 21. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative health eating index and the Dietary Guidelines from American Diabetes Association both may reduce the risk of cardiovascular disease in type 2 diabetes patients.
    Wu PY; Huang CL; Lei WS; Yang SH
    J Hum Nutr Diet; 2016 Jun; 29(3):363-73. PubMed ID: 26010198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between metabolic syndrome and 10-year risk for incident type 2 diabetes mellitus].
    Li Y; Zhao D; Wang W; Liu J; Cheng J; Liu Q; Liu J; Jia YN; Sun JY; Qin LP; Wu ZS
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1245-8. PubMed ID: 17686257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular mortality in Korea: a country experiencing epidemiologic transition.
    Suh I
    Acta Cardiol; 2001 Apr; 56(2):75-81. PubMed ID: 11357928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-insulin-dependent diabetes and 11-year mortality in Asian Indian and Melanesian Fijians.
    Collins VR; Dowse GK; Ram P; Cabealawa S; Zimmet PZ
    Diabet Med; 1996 Feb; 13(2):125-32. PubMed ID: 8641116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus.
    Dutton GR; Lewis CE
    Prog Cardiovasc Dis; 2015; 58(1):69-75. PubMed ID: 25936906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.
    Wannamethee SG; Shaper AG; Walker M
    J Epidemiol Community Health; 2005 Feb; 59(2):134-9. PubMed ID: 15650145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing cardiovascular risk factors and selecting agents to successfully treat patients with type 2 diabetes mellitus.
    Baldwin MD
    J Am Osteopath Assoc; 2011 Jul; 111(7 Suppl 5):S2-12. PubMed ID: 21813732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why have sustained increases in obesity and type 2 diabetes not offset declines in cardiovascular mortality over recent decades in Western countries?
    Capewell S; Buchan I
    Nutr Metab Cardiovasc Dis; 2012 Apr; 22(4):307-11. PubMed ID: 22405577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association Between Type 2 Diabetes and Cardiovascular Disease: The "For Your SweetHeart™" Survey.
    Perreault L; Boardman MK; Pak J
    Adv Ther; 2019 Mar; 36(3):746-755. PubMed ID: 30758740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes and cardiovascular disease: reducing the risk.
    Bartels DW; Davidson MH; Gong WC
    J Manag Care Pharm; 2007 Mar; 13(2 Suppl A):S2-15; quiz S16-7. PubMed ID: 17330977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes.
    Tanasescu M; Leitzmann MF; Rimm EB; Hu FB
    Circulation; 2003 May; 107(19):2435-9. PubMed ID: 12719277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 'thrifty' hypotheses: clinical and epidemiological significance for non-insulin-dependent diabetes mellitus and cardiovascular disease risk factors.
    Chukwuma C; Tuomilehto J
    J Cardiovasc Risk; 1998 Feb; 5(1):11-23. PubMed ID: 9816551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.
    Sánchez-Romero LM; Penko J; Coxson PG; Fernández A; Mason A; Moran AE; Ávila-Burgos L; Odden M; Barquera S; Bibbins-Domingo K
    PLoS Med; 2016 Nov; 13(11):e1002158. PubMed ID: 27802278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging economies and diabetes and cardiovascular disease.
    Pradeepa R; Prabhakaran D; Mohan V
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1():S59-67. PubMed ID: 22650226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 2 diabetes mellitus in Augsburg--an epidemiological overview.
    Meisinger C; Döring A; Heier M; Thorand B; Löwel H;
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S103-9. PubMed ID: 16032526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public health significance of four cardiovascular risk factors assessed 25 years ago in a low prevalence country.
    Faeh D; Braun J; Tarnutzer S; Bopp M
    Eur J Prev Cardiol; 2013 Feb; 20(1):151-60. PubMed ID: 22080525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002.
    Kanjilal S; Gregg EW; Cheng YJ; Zhang P; Nelson DE; Mensah G; Beckles GL
    Arch Intern Med; 2006 Nov; 166(21):2348-55. PubMed ID: 17130388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.